title: Prophecy about post-endoscopic retrograde cholangiopancreatography pancreatitis: from divination to science.
abstract: One unresolved issue of endoscopic retrograde cholangiopancreatography (ERCP) is post-ERCP pancreatitis (PEP), which occurs in up to 40% of patients. Identification of risk factors for PEP is especially important in the field of ERCP practice because it may assist physicians in taking protective measures in situations with high risk. A decade ago, Freeman et al meticulously evaluated a large number of potentially relevant risk factors for PEP, which can be divided into patient-related and procedure-related issues. In this commentary, we summarize this classic article and reevaluate the risk factors for PEP from the current point of view. This is followed by assessment of strategies for prevention of PEP that can be divided into mechanical and pharmacologic methods.
authors: Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 431-070, South Korea.
authors: Sung-Hoon
authors: SH
authors: Moon
authors: Myung-Hwan
authors: MH
authors: Kim
mesh_terms: D000818:Animals; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects* / Q000266:history; D049674:History, 21st Century; D006801:Humans; D010195:Pancreatitis / Q000209:etiology / Q000266:history / Q000517:prevention & control*; D018579:Patient Selection; D011379:Prognosis; D012307:Risk Factors
keywords: Endoscopic retrograde cholangiopancreatography; Nonsteroidal antiinflammatory drugs; Pancreatic stents; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis; Risk factor